All Updates

All Updates

icon
Filter
Product updates
Mycorena discontinues Swedish factory project; shifts focus to circular production model
Plant-based Dairy & Egg
Jun 13, 2024
This week:
Partnerships
Anthropic partners with Amazon Bedrock to fine-tune Claude 3 Haiku model
Foundation Models
Yesterday
Funding
Lemon.markets raises EUR 12 million in funding to support growth
FinTech Infrastructure
Yesterday
M&A
Kipu Quantum acquires PlanQK platform to enhance accessibility to quantum computing solutions
Quantum Computing
Yesterday
Partnerships
Quantinuum and STFC Hartree Centre partner to enhance quantum computing accessibility in UK
Quantum Computing
Yesterday
M&A
Ipsen licenses Foreseen's antibody-drug conjugate 'FS001' for first-in-class cancer treatment development
Precision Medicine
Yesterday
M&A
Ipsen licenses Foreseen's antibody-drug conjugate 'FS001' for first-in-class cancer treatment development
AI Drug Discovery
Yesterday
Partnerships
Beacon Therapeutics collaborates with Abeona Therapeutics for ophthalmic gene therapy development
Cell & Gene Therapy
Yesterday
Funding
Pan Cancer T raises EUR 4.25 million in seed extension funding for preclinical studies of PCT1:CO-STIM TCR T-cell therapy
Cell & Gene Therapy
Yesterday
Partnerships
Accelerated Biosciences and Pluristyx partner to create clinical-grade induced pluripotent stem cell lines
Cell & Gene Therapy
Yesterday
M&A
SoftBank acquires UK AI chipmaker Graphcore to improve AI capabilities
Edge Computing
Yesterday
Plant-based Dairy & Egg

Plant-based Dairy & Egg

Jun 13, 2024

Mycorena discontinues Swedish factory project; shifts focus to circular production model

Product updates

  • Mycorena, a Swedish alternative protein producer, has discontinued its planned factory project in Sweden for Promyc, its principal mycoprotein ingredient. The company claims that a market shift and decreased investor interest in high-capital investment projects have led to this decision.

  • Mycorena will now shift its focus to a B2B2C approach, utilizing a sustainable circular upcycling production model by capitalizing on its Gothenburg demo plant's capacity, maintaining existing collaborations, and searching for new opportunities with private brands and foodservice entities. The company expects the Gothenburg plant will produce enough mycoprotein ingredients for up to 500 tons of consumer products.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.